ARTISS Solutions for Sealant, deep frozen
Authorisation PA2299/026/001 · Baxter Holding B.V.
- Licence holder
- Baxter Holding B.V. (all products →)
- Active substances
- Human fibrinogen, Human thrombin, Calcium chloride, Aprotinin
- Clinical trials
- 3 clinical trials →
- Dosage form
- Solution for sealant
- Routes of administration
- Epilesional use, Topical use
- ATC codes
- B02BC, V03AK
- First authorised
- 03/07/2009
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Human fibrinogen: supply and approvals
8 authorised products on the HPRA list contain Human fibrinogen. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Human thrombin: supply and approvals
3 authorised products on the HPRA list contain Human thrombin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Calcium chloride: supply and approvals
55 authorised products on the HPRA list contain Calcium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- 1 supply notice, e.g. OsvaRen (24 Mar 2025 to 31 Mar 2027)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 17 years (since 3 July 2009). The HPRA list marks it as marketed in Ireland.
Other medicines with Human fibrinogen in Ireland
7 other products on the HPRA list contain Human fibrinogen, from 4 licence holders; 3 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| FIBRYGA, 1 g, powder and solvent for solution for injection/infusion | Octapharma (IP) | National authorisation (PA) | Marketed |
| TISSEEL Lyo Powder and Solvent for Sealant | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| TISSEEL Ready to use Solutions for Sealant | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| FIBRYGA 2 g powder and solvent for solution for injection/infusion | Octapharma (IP) | National authorisation (PA) | Not marketed |
| Riastap 1 g Powder for Solution for Injection/Infusion | CSL Behring GmbH | National authorisation (PA) | Not marketed |
| VeraSeal 80 mg/ml/500 IU/ml Solutions for sealant | Instituto Grifols S.A. | Centralised EU authorisation | Not stated |
| VeraSeal 80 mg/ml/500 IU/ml Solutions for sealant | Instituto Grifols S.A. | Centralised EU authorisation | Not stated |
Other medicines with Human thrombin in Ireland
2 other products on the HPRA list contain Human thrombin, from 1 licence holder; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| TISSEEL Lyo Powder and Solvent for Sealant | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| TISSEEL Ready to use Solutions for Sealant | Baxter Holding B.V. | National authorisation (PA) | Marketed |
Other substances in ATC group B02BC
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group B02BC with this product:
Human factor xiii (2) · Fibrinogen (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Baxter Holding B.V. holds 73 products on the HPRA list, with 111 different active substances; 62 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.